New study successfully made CTC-derived organoids from breast cancer patients' blood samples to investigate cell survival and ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

Mersana on Friday said the new designation covers the drug, XMT-1660, for the treatment of advanced or metastatic breast cancer in patients with human epidermal growth factor receptor 2 low or ...

The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response ...

Cancer researchers at the University of Leicester have developed a technique that could predict how well some breast cancer ...

Stacey Stevens, who has ample experience using artificial intelligence to aid with cancer treatment, replaces co-founder Tushar Pandey.

Elisabeth Potter, a doctor based in Austin, Texas, created a video on Instagram detailing her experience treating a cancer ...

Phase 3 data support pyrotinib plus trastuzumab and docetaxel “as a well-established and effective treatment strategy,” according to Binghe Xu, MD.

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

New breast cancer drug given green light for NHS use - Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer.

Incredible” results from the PATINA trial suggested a new standard of care for HER2, ER-positive metastatic breast cancer.